Jazz Pharmaceuticals Plc (JAZZ)
243.71
-6.97
(-2.78%)
USD |
NASDAQ |
Sep 01, 16:00
243.76
+0.05
(+0.02%)
After-Hours: 07:00
Jazz Pharmaceuticals Cash from Operations (Annual) : 1.356B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.356B |
| December 31, 2024 | 1.396B |
| December 31, 2023 | 1.092B |
| December 31, 2022 | 1.272B |
| December 31, 2021 | 778.51M |
| December 31, 2020 | 899.65M |
| December 31, 2019 | 776.40M |
| December 31, 2018 | 792.50M |
| December 31, 2017 | 693.09M |
| December 31, 2016 | 590.54M |
| December 31, 2015 | 531.94M |
| Date | Value |
|---|---|
| December 31, 2014 | 405.76M |
| December 31, 2013 | 283.62M |
| December 31, 2012 | 249.75M |
| December 31, 2011 | 151.60M |
| December 31, 2010 | 58.87M |
| December 31, 2009 | -13.46M |
| December 31, 2008 | -130.23M |
| December 31, 2007 | -81.09M |
| December 31, 2006 | -57.35M |
| December 31, 2005 | -52.16M |
| December 31, 2004 | -21.16M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| Perrigo Co. Plc | 238.50M |
| GH Research Plc | -43.55M |
| Cosmo NV | -13.02M |
| Axsome Therapeutics, Inc. | -93.40M |